Treatment of rheumatoid arthritis with 3-amino lactam compounds
US8853200B2 · kind B2 · utility
0Cited by
8References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2008 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | May 28, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 3-(2′,2′-dimethylpropanoylamino)-tetrahydropyridin-2-one, and its pharmaceutical compositions and its use for preparing a medicament intended to prevent or treat inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.